Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded company by revenue, the Melville-based company announced Wednesday.

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and distributor.

Japan's share of all private equity and venture capital investments in Asia-Pacific grew in 2024 as the value of private equity deals targeting Japanese companies surged. Click to read.

Indiana and Connecticut are among the half-dozen states where lawmakers in recent days proposed checks on healthcare mergers.

The market also is very fragmented: In the prospectus for its initial public offering last year, Centuri Holdings Inc. executives cited ENR and S&P Global research stating that the five largest utility service providers—which include Quanta Services Inc. and Centuri—claimed only 18% of the industry’s revenues in 2022.

Private equity investment in law firms is resurfacing as a hot topic, sparking renewed speculation that the trend will gain momentum in the years ahead.

Shares of KKR & Co Inc (KKR) and Henry Schein drew retail attention on Wednesday after it was revealed that the private equity giant will become a 12% common shareholder in the healthcare solutions firm.

Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read more here.